Raymond James Lowers UnitedHealth Group (NYSE:UNH) to Outperform

UnitedHealth Group (NYSE:UNHGet Rating) was downgraded by equities research analysts at Raymond James from a “strong-buy” rating to an “outperform” rating in a research report issued to clients and investors on Monday, The Fly reports. They presently have a $615.00 target price on the healthcare conglomerate’s stock. Raymond James’ price target would indicate a potential upside of 17.57% from the company’s current price.

Other equities research analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $569.00 to $615.00 and gave the stock a “buy” rating in a report on Tuesday, October 18th. Argus boosted their price target on UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday, July 25th. StockNews.com initiated coverage on UnitedHealth Group in a research report on Wednesday, October 12th. They issued a “strong-buy” rating for the company. Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, August 10th. Finally, Royal Bank of Canada increased their price objective on shares of UnitedHealth Group from $588.00 to $592.00 and gave the stock an “outperform” rating in a report on Monday, October 17th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $595.11.

UnitedHealth Group Stock Performance

Shares of UNH opened at $523.09 on Monday. The company has a 50-day moving average of $523.65 and a two-hundred day moving average of $515.60. The stock has a market cap of $488.75 billion, a P/E ratio of 25.62, a PEG ratio of 1.65 and a beta of 0.75. UnitedHealth Group has a 12-month low of $436.00 and a 12-month high of $558.10. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, October 14th. The healthcare conglomerate reported $5.79 EPS for the quarter, beating analysts’ consensus estimates of $5.45 by $0.34. UnitedHealth Group had a return on equity of 26.59% and a net margin of 6.17%. The firm had revenue of $80.89 billion for the quarter, compared to analysts’ expectations of $80.54 billion. During the same quarter in the prior year, the firm earned $4.52 EPS. UnitedHealth Group’s quarterly revenue was up 11.8% on a year-over-year basis. As a group, research analysts predict that UnitedHealth Group will post 22.01 EPS for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Wealthstream Advisors Inc. raised its stake in UnitedHealth Group by 4.4% during the second quarter. Wealthstream Advisors Inc. now owns 452 shares of the healthcare conglomerate’s stock valued at $232,000 after buying an additional 19 shares in the last quarter. CoreCap Advisors LLC boosted its holdings in UnitedHealth Group by 0.5% in the second quarter. CoreCap Advisors LLC now owns 4,217 shares of the healthcare conglomerate’s stock worth $2,166,000 after purchasing an additional 19 shares during the period. Elgethun Capital Management lifted its position in shares of UnitedHealth Group by 0.3% in the 2nd quarter. Elgethun Capital Management now owns 6,577 shares of the healthcare conglomerate’s stock worth $3,369,000 after buying an additional 19 shares during the last quarter. Hollencrest Capital Management grew its position in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Hollencrest Capital Management now owns 2,337 shares of the healthcare conglomerate’s stock valued at $1,180,000 after buying an additional 19 shares during the last quarter. Finally, Smith Salley & Associates increased its position in UnitedHealth Group by 0.7% in the third quarter. Smith Salley & Associates now owns 2,873 shares of the healthcare conglomerate’s stock worth $1,451,000 after buying an additional 19 shares during the period. Institutional investors own 87.25% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.